Adelphi Capital LLP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 316 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
Adelphi Capital LLP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q4 2020$138,046,000
-6.5%
7,584,930
-8.3%
26.79%
-6.6%
Q3 2020$147,612,000
-10.1%
8,274,227
-9.6%
28.67%
-20.4%
Q2 2020$164,172,000
+16.5%
9,156,315
-1.4%
36.01%
+6.5%
Q1 2020$140,909,000
-20.3%
9,282,543
+3.6%
33.82%
+0.2%
Q4 2019$176,757,000
+14.3%
8,958,784
-0.4%
33.75%
+1.0%
Q3 2019$154,650,000
+10.2%
8,991,290
+13.4%
33.43%
+1.5%
Q2 2019$140,381,000
-25.7%
7,931,116
-14.4%
32.92%
-15.9%
Q1 2019$188,841,0009,270,53539.13%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2019
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders